Literature DB >> 2647627

The distribution of immunoreactive interferon-alpha in normal human tissues.

N U Khan1, K A Pulford, M A Farquharson, A Howatson, C Stewart, R Jackson, A M McNicol, A K Foulis.   

Abstract

The cellular distribution of immunoreactive interferon-alpha (IFN-alpha) was studied in formalin-fixed paraffin-embedded normal human tissues from 36 different organs. These samples were drawn from over 300 individuals none of whom had evidence of viral infection. Tissue histiocytes from all organs in the body, with the exception of brain and renal cortex and medulla, stained positively for IFN-alpha. Kupffer cells, pulmonary alveolar macrophages and lymph node macrophages were also positive. Parenchymal cells in some other organs also appeared to contain immunoreactive IFN-alpha. These included cuboidal lining cells of the choroid plexus in the brain, thyroid follicular cells, pituitary endocrine cells, adrenocortical cells and parathyroid principal and oxyphil cells. These findings are compatible with previous suggestions that IFN-alpha may be synthesized and released in the absence of viral infection and may thus have a role in normal physiology. The presence of IFN-alpha in most cells of the mononuclear phagocyte system suggests that these cells may play a major part in defence against viral infection.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2647627      PMCID: PMC1385087     

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  18 in total

1.  Virus interference. I. The interferon.

Authors:  A ISAACS; J LINDENMANN
Journal:  Proc R Soc Lond B Biol Sci       Date:  1957-09-12

2.  Production and role of interferon in physiological conditions.

Authors:  V Bocci
Journal:  Biol Rev Camb Philos Soc       Date:  1981-02

3.  Monocyte is the main producer of human leukocyte alpha interferons following Sendai virus induction.

Authors:  E Saksela; I Virtanen; T Hovi; D S Secher; K Cantell
Journal:  Prog Med Virol       Date:  1984

4.  Interferon is a mediator of hematopoietic suppression in aplastic anemia in vitro and possibly in vivo.

Authors:  N C Zoumbos; P Gascon; J Y Djeu; N S Young
Journal:  Proc Natl Acad Sci U S A       Date:  1985-01       Impact factor: 11.205

5.  Continuous production of interferon in normal mice: effect of anti-interferon globulin, sex, age, strain and environment on the levels of 2-5A synthetase and p67K kinase.

Authors:  J Galabru; N Robert; C Buffet-Janvresse; Y Rivière; A G Hovanessian
Journal:  J Gen Virol       Date:  1985-04       Impact factor: 3.891

6.  Injection of mice with antibody to interferon renders peritoneal macrophages permissive for vesicular stomatitis virus and encephalomyocarditis virus.

Authors:  F Belardelli; F Vignaux; E Proietti; I Gresser
Journal:  Proc Natl Acad Sci U S A       Date:  1984-01       Impact factor: 11.205

7.  The physiological interferon response. II. Interferon is present in lymph but not in plasma of healthy rabbits.

Authors:  V Bocci; M Muscettola; L Paulesu; G Grasso
Journal:  J Gen Virol       Date:  1984-01       Impact factor: 3.891

8.  A comparison of the neutralizing properties of monoclonal and polyclonal antibodies to human interferon alpha.

Authors:  T Exley; S Parti; S Barwick; A Meager
Journal:  J Gen Virol       Date:  1984-12       Impact factor: 3.891

9.  Injection of mice with antibody to interferon enhances the growth of transplantable murine tumors.

Authors:  I Gresser; F Belardelli; C Maury; M T Maunoury; M G Tovey
Journal:  J Exp Med       Date:  1983-12-01       Impact factor: 14.307

10.  Rabbit macrophage interferons. I. Conditions for biosynthesis by virus-infected and uninfected cells.

Authors:  T J Smith; R R Wagner
Journal:  J Exp Med       Date:  1967-04-01       Impact factor: 14.307

View more
  18 in total

1.  Independence of measles-specific humoral and cellular immune responses to vaccination.

Authors:  Robert M Jacobson; Inna G Ovsyannikova; Robert A Vierkant; V Shane Pankratz; Gregory A Poland
Journal:  Hum Immunol       Date:  2012-03-03       Impact factor: 2.850

2.  The distribution of immunoreactive interferon-gamma-containing cells in normal human tissues.

Authors:  F Brett; A Mowat; M A Farquharson; M McGill; C Hind; J Richmond; D Murray; N U Khan; A K Foulis
Journal:  Immunology       Date:  1992-12       Impact factor: 7.397

Review 3.  Clinical pharmacokinetics of interferons.

Authors:  R J Wills
Journal:  Clin Pharmacokinet       Date:  1990-11       Impact factor: 6.447

Review 4.  Potential role of type I interferons in the treatment of pituitary adenomas.

Authors:  Giovanni Vitale; Michele Caraglia; Peter M van Koetsveld; Paola Maroni; Monica Marra; Annamaria Colao; Steven W J Lamberts; Francesco Cavagnini; Leo J Hofland
Journal:  Rev Endocr Metab Disord       Date:  2008-07-06       Impact factor: 6.514

5.  Interferon-alpha and IDDM: comment.

Authors:  A K Foulis
Journal:  Diabetologia       Date:  1996-01       Impact factor: 10.122

6.  Neurons produce type I interferon during viral encephalitis.

Authors:  Sophie Delhaye; Sophie Paul; Gjon Blakqori; Muriel Minet; Friedemann Weber; Peter Staeheli; Thomas Michiels
Journal:  Proc Natl Acad Sci U S A       Date:  2006-05-08       Impact factor: 11.205

7.  The distribution of immunoreactive interferon-alpha in formalin-fixed paraffin-embedded normal human foetal and infant tissues.

Authors:  N U Khan; A Gibson; A K Foulis
Journal:  Immunology       Date:  1990-10       Impact factor: 7.397

8.  Hepatic alpha-interferon expression in cytomegalovirus-infected liver allograft recipients with and without vanishing bile duct syndrome.

Authors:  J C Arnold; K T Nouri-Aria; J G O'Grady; B C Portmann; G J Alexander; R Williams
Journal:  Clin Investig       Date:  1993-03

9.  Immunolocalization of alpha interferon in liver disease.

Authors:  C G Sutherland; A M al-Badri; A G Howatson; M A Farquharson; A K Foulis
Journal:  J Clin Pathol       Date:  1989-10       Impact factor: 3.411

10.  Selective production of interferon-alpha subtypes by cultured peripheral blood mononuclear cells and lymphoblastoid cell lines.

Authors:  A L Greenway; M L Overall; N Sattayasai; M J Rowley; P J Hertzog; G L McMullen; B F Cheetham; S Marzuki
Journal:  Immunology       Date:  1992-01       Impact factor: 7.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.